The uncomfortable, well-documented fact
Published extension studies and real-world data agree: when people stop GLP-1 therapy abruptly, most regain a substantial portion of the weight over the following year. Appetite signaling returns to baseline; the biology that made weight loss hard before comes back online. This isn't a personal failure and it isn't unique to any brand — it's how chronic appetite regulation works.
Knowing that upfront changes how you plan. The question isn't just "how do I lose it?" but "what's my maintenance plan when I get there?"
Your realistic options at goal weight
1. Continue at your effective dose
Some patients simply stay on therapy, the way people stay on blood-pressure medication. With flat pricing (no dose-based increases at Agave), the cost is predictable.
2. Step down to a lower maintenance dose
A common middle path: reduce to the lowest dose that keeps appetite manageable. This is provider-guided territory — and it's structurally what our low-dose programs are built for, from $169/mo.
3. Space doses out
Some providers use extended intervals (e.g., a weekly injection stretched further apart) as a taper strategy. Evidence here is thinner than for standard dosing — treat it as a supervised experiment with honest tracking.
4. Taper off fully, with a plan
If your goal is to exit entirely: taper rather than stop cold where your provider agrees, and go in with the habits that survive the medication — protein-forward meals, resistance training to protect muscle, sleep, and a weight-tracking cadence with a pre-agreed re-entry threshold ("if I regain X, I restart the conversation").
What we'd tell a friend
- Decide the maintenance question with your provider before you're at goal, not after regain starts.
- Whatever path you pick, protect muscle: strength training + protein are the difference between losing weight and losing the right weight.
- Beware any program that makes quitting hard or restarting punitive. You should be able to pause, step down, or stop without games — see our cancellation policy.
Related: the microdosing guide · managing side effects